Gene therapy will not reach its full potential as a transformative treatment for genetic diseases unless manufacturing ...

Experiments revealed the profound influence of microenvironmental context on uropathogenic E. coli infection dynamics and ...

Preclinical findings are the basis for an upcoming Phase II clinical trial evaluating psilocybin during chemotherapy in ...

Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in macaques and may inform future HIV cure ...

The DARPA project had the potential to improve athletic performance and help treat conditions involving a lack of oxygen in ...

New research models plasmid competition in E. coli, with implications for biotechnology, antibiotics, and probiotics.

The Boulder, CO, site is scheduled to become operational in the second half of 2027, following completion and qualification.

Cell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but ...

Study identifies a gene that could potentially be targeted in human pancreatic duct cells to replenish β cell mass for ...

A new spatial transcriptomics framework compares tumor “floor plans,” revealing conserved spatial groups that may relate ...

Life sciences industry group MassBio finds that growth-stage companies based in the Bay State are reaping the fruits of ...